A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe
Completed
- Conditions
- Ophthalmology, Macular Degeneration
- Interventions
- Other: Physician questionnaire
- Registration Number
- NCT04067583
- Lead Sponsor
- Bayer
- Brief Summary
With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 454
Inclusion Criteria
- Has signed informed consent
- Is a licensed and practicing ophthalmologist
- Has prescribed and/or administered aflibercept to at least one patient in the past 6 months
Read More
Exclusion Criteria
- None
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Physicians with recent aflibercept experience Physician questionnaire Ophthalmologists who have prescribed and/or administered aflibercept in the past 6 months
- Primary Outcome Measures
Name Time Method Percentage of physicians responding correctly to each individual knowledge question Up to 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Many locations
🇩🇪Multiple Locations, Germany